Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy.

Springerplus · 2015 · PMC4519490 · PMID 26240784

Europe PMC DOI

hedged sentence

0.4100

closest p · 8.2× alpha

0.4100

boldest claim

The sentences

did not reach statistical significancep = 0.41not close (p > 0.1)

In non-pCR group, the highest rate of DM was seen in TNBCs (20.6%), compared with HR+/HER2− (14.8%) and HER2+ subtypes (14.7%) but the difference did not reach statistical significance (p = 0.41 and p = 0.75, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.